Literature DB >> 15343265

HLA-DRB1, TAP2/TAP1, and HLA-DPB1 haplotypes in Finnish juvenile idiopathic arthritis: more complexity within the MHC.

J A Runstadler1, H Säilä, A Savolainen, M Leirisalo-Repo, K Aho, E Tuomilehto-Wolf, J Tuomilehto, M F Seldin.   

Abstract

This study further defines genetic susceptibility to JIA in the region centromeric to HLA-DRB1. DNA from 234 Finnish JIA nuclear families and 639 elderly Finnish control individuals was genotyped for five functional SNPs within the TAP2 and TAP1 loci ( approximately 200 kb centromeric of HLA-DRB1). Subsets of the controls (186) and patients (145) that had been previously typed for HLA-DRB1 were also genotyped by sequence for the HLA-DPB1 locus. Case/control and transmission disequilibrium test (TDT) methods revealed an association with the DPB1(*)030101 allele for JIA (OR 2.3, 95% CI 1.5-3.5). Notably, a detailed haplotypic analysis of the TAP2/TAP1 loci and their interaction with the HLA-DPB1(*)030101 and DRB1(*)08 and (*)11 alleles showed a variety of over-represented and under-represented TAP2/TAP1 haplotypes not evident in the single marker analysis. The strongest effect was observed in the polyarticular RF negative JIA subgroup for the 2-2-1-2-1 TAP2/TAP1 haplotype (TAP2B and TAP1A alleles) which showed an independent effect from both DRB1(*)08 and (*)11 (P<0.000003) and DPB1(*)030101 (P=0.02). We have provided evidence that the extended haplotypes (including HLA-DRB1, TAP2/TAP1, and HLA-DPB1) of pauciarticular and polyarticular RF negative disease are distinct. This observation may have implications for functional etiological differences between the pauciarticular and polyarticular JIA patients.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15343265     DOI: 10.1038/sj.gene.6364129

Source DB:  PubMed          Journal:  Genes Immun        ISSN: 1466-4879            Impact factor:   2.676


  1 in total

1.  Classical HLA-DRB1 and DPB1 alleles account for HLA associations with primary biliary cirrhosis.

Authors:  P Invernizzi; M Ransom; S Raychaudhuri; R Kosoy; A Lleo; R Shigeta; A Franke; F Bossa; C I Amos; P K Gregersen; K A Siminovitch; D Cusi; P I W de Bakker; M Podda; M E Gershwin; M F Seldin
Journal:  Genes Immun       Date:  2012-05-10       Impact factor: 2.676

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.